Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 3/20 | 0.31 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.31 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.31 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.31 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.30 |
| ▸ | CPT2 | P23786 | 1/20 | 0.30 |
| ▸ | CPT1A | P50416 | 1/20 | 0.30 |
| ▸ | GABRP | O00591 | 4/20 | 0.30 |
| ▸ | GABRD | O14764 | 4/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.30 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12809879 | 0.75 | — | — | |
| SCHEMBL26632580 | 0.75 | — | — | |
| SCHEMBL3973664 | 0.75 | ALDH1A1 (0.32) | — | |
| SCHEMBL24040207 | 0.74 | — | — | |
| SCHEMBL25083763 | 0.74 | ENPEP (0.39) | ENPEPCPT2CPT1AGABRPGABRD | |
| SCHEMBL23464806 | 0.74 | — | — | |
| SCHEMBL10519890 | 0.72 | — | — | |
| SCHEMBL5686558 | 0.72 | — | — | |
| SCHEMBL7397717 | 0.72 | — | — | |
| SCHEMBL469068 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11173109-B2 | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid | ADOCIA (FR) | 2021-11-16 | — | — | US | disclosed |
| US-20190274954-A1 | Copositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid | ADOCIA (FR) | 2019-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190274954-A1 | Copositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid | IAPP, GLP1R, INSR | GRIK1 2672/4885GRIA2 1273/4885GRIA4 789/4885 |
| US-11173109-B2 | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid | IAPP, INSR, GLP1R | GRIK1 2464/4885GRIA2 1548/4885GRIA4 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.